• 1
    Chang L, Toner BB, Fukudo S et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 143546.
  • 2
    Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 148091.
  • 3
    Gralnek IM, Hays RD, Kilbourne AM et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 65460.
  • 4
    Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol 1993; 17: 13341.
  • 5
    Barbara G, De Giorgio R, Stanghellini V et al. A role for inflammation in irritable bowel syndrome? Gut 2002; 51(Suppl. 1): i414.
  • 6
    Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immun 2004; 5: 56973.
  • 7
    Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 166271.
  • 8
    Verdú EF, Bercik P, Verma-Gandhu M et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006; 55: 18290.
  • 9
    O’Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relational to cytokine profiles. Gastroenterology 2005; 128: 54151.
  • 10
    Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13: 357.
  • 11
    Malinen E, Rinttilä T, Kajander K et al. Analysis of the microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 37382.
    Direct Link:
  • 12
    Kassinen A, Kroqius-Kurikka L, Mökivuokko H et al. The feacal microbiota of irritable bowel syndrome patients differs significantly from that of health subjects. Gastroenterology 2007; 133: 2433.
  • 13
    Franks AH, Harmsen HJ, Raangs GC et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S r RNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64: 333645.
  • 14
    Koide A, Yamaguchi T, Odaka T et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 173541.
    Direct Link:
  • 15
    Mortensen PB, Andersen JR, Arffmann S et al. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 1987; 22: 18592.
  • 16
    Treem WR, Ahsan N, Kastoff G et al. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996; 23: 2806.
  • 17
    Tompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): II437.
  • 18
    Drossman DA, Talley NJ, Whitehead WE, et al. Research diagnostic questions for functional gastrointestinal disorders: Rome II modular questionnaire: investigations and respondent forms. In: DrossmanDA, CorazziariE, TalleyNJ, ThompsonWG, eds. Rome II: The Functional Gastrointestinal Disorders, 2nd edn. McLean, VA: Degnon Associates, 2000: 669714.
  • 19
    Matsumoto K, Takada T, Shimizu K et al. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microbiota of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Micobiota 2006; 25: 3948.
  • 20
    Brigidi P, Vitali B, Swennen E et al. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152: 73541.
  • 21
    Matsuki T, Watanabe K, Fujimoto J et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004; 70: 72208.
  • 22
    Matsuki T, Fujimoto J, Watanabe K. Group-specific PCR primers for the detection of human intestinal bacteria. Japanese patent 2007–20423.
  • 23
    Matsuki T, Watanabe K, Fujimoto J et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002; 68: 544551.
  • 24
    Kikuchi H, Tajima T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Agric 1992; 60: 13946.
  • 25
    Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395402.
  • 26
    Svedlund J, Sjödin I, Dotevall G. GSRS – a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 12934.
  • 27
    Shinozaki M, Fukudo S, Hongo M et al. High prevalence of irritable bowel syndrome in medical out-patients in Japan. J Clin Gastroenterol 2008; 42: 10106.
  • 28
    Drossman DA, Patrick DL, Whitehead WE et al. Futher validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95: 9991007.
    Direct Link:
  • 29
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 30
    Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 6370.
  • 31
    Speilberger CD, Gorsuch RL, Lushene RE. STAI Manual. Palo Alto (CA): Consulting Psychologist Press, 1970: 2349.
  • 32
    Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325: 60612.
  • 33
    Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale – I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994; 38: 2332.
  • 34
    Taylor GJ. Recent developments in alexithymia theory and research. Can J Psychiatry 2000; 45: 13442.
  • 35
    Hoverstad T, Bjornaklett A, Fausa O et al. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol 1985; 20: 4929.
  • 36
    Hoverstad T, Carlstedt-Duke B, Lingaas E et al. Influence of oral intake of seven different antibiotics on faecal short-chain fatty acid excretion in health subjects. Scand J Gastroenterol 1986; 21: 9971003.
  • 37
    Hegazi FZ, Abo-Elinaga IG. Degradation of organic acids by dairy lactic acid bacteria. Zentralbl Bakteriol Naturwiss 1980; 135: 21222.
  • 38
    Durant JA, Nisbet DJ, Ricke SC. Comparison of batch culture growth and fermentation of a poultry Veillonella isolate and selected Veillonella species groen in a defined medium. Anaerobe 1997; 3: 3917.
  • 39
    Aerssens J, Hillsley K, Peeters PJ et al. Alteration in the brain–gut axis underlying visceral hypersensitivity in Nippostrongylus brasilinensis-infected mice. Gastroenterology 2007; 132: 137587.
  • 40
    Tominaga M, Julius D. Capsaicin receptor in the pain pathway. Jpn J Pharmacol 2000; 83: 204.
  • 41
    Winston J, Shenoy M, Medley D et al. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007; 132: 61527.
  • 42
    Chan CLH, Facer P, Davis JB et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and feacal urgency. Lancet 2003; 361: 38591.
  • 43
    Brierley SM, Hughes PA, Page AJ et al. Novel and specific roles for the inon channel TRPA1 in visceral sensory transduction. Gastroenterology 2008; 134(Suppl. 1): A8.
  • 44
    Michl T, Jocic M, Heinemann A et al. Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 2001; 92: 1927.
  • 45
    Drossman DA, Morris CB, Hu Y et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005; 128: 5809.